Doctor profile · Federal record
Dr. SRIKAR VEERAREDDY, M.D.
Clinical Cardiac Electrophysiology Physician (CMS: CARDIOVASCULAR DISEASE (CARDIOLOGY)) · Cardiovascular Disease Physician · SHREVEPORT, LA
- NPI 1871512954
- Accepts Medicare
- MIPS 71.0 / 100 · 2023
- 30 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1453 E BERT KOUN LOOP STE 112
SHREVEPORT, LA 711056810
(318) 798-9400 - Mailing address
-
PO BOX 51008
SHREVEPORT, LA 711351008
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- August 12, 2022
- Year of graduation
- 1996 — 30 yrs since
- Specialty taxonomy
- 207RC0001X — NUCC code
- State license (1)
- Louisiana #MD.15758R
- Medicaid
- LA #1071471
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1871512954. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
5,163
Distinct HCPCS
10
Medicare allowed
$411,208
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
93000 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,251 | 753 | $13 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 567 | 432 | $84 | |
93297 |
Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 525 | 66 | $25 | |
93294 |
Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 465 | 144 | $29 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 456 | 336 | $119 | |
93295 |
Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 251 | 78 | $35 | |
93015 |
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 217 | 217 | $59 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 188 | 167 | $166 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 160 | 77 | $76 | |
93306 |
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 143 | 140 | $171 |
In context: peer comparison
Among 5 peers in this city , average services per provider: 88. This provider delivers 59× the peer median.Open Payments
Industry payments received
All-time total
$1,591
Transactions
88
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| CARDIVA MEDICAL, INC. | 18 | $357.79 | |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 29 | $355.54 | |
| Inari Medical, Inc. | 15 | $344.22 | |
| Boston Scientific Corporation | 13 | $238.59 | |
| Medtronic, Inc. | 3 | $75.68 | |
| Abbott Laboratories | 2 | $49.26 | |
| Biosense Webster, Inc. | 1 | $48.42 | |
| ABIOMED | 2 | $37.55 | |
| Baxter Healthcare | 1 | $22.11 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $21.51 | |
| Elutia, Inc. | 1 | $15.54 | |
| SANOFI-AVENTIS U.S. LLC | 1 | $14.43 | |
| Itamar Medical Inc | 1 | $10.57 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
3,435
Patients
857
Total drug cost
$764,427
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Metoprolol Succinate | Generic | 466 | 134 | $6,536 |
| Eliquis (Apixaban) | Brand | 463 | 82 | $337,630 |
| Carvedilol | Generic | 340 | 80 | $2,317 |
| Flecainide Acetate | Generic | 295 | 60 | $9,628 |
| Furosemide | Generic | 263 | 80 | $1,094 |
| Atorvastatin Calcium | Generic | 261 | 66 | $2,432 |
| Amlodipine Besylate | Generic | 242 | 62 | $1,336 |
| Xarelto (Rivaroxaban) | Brand | 226 | 51 | $225,460 |
| Entresto (Sacubitril/Valsartan) | Brand | 187 | 39 | $170,465 |
| Metoprolol Tartrate | Generic | 138 | 34 | $1,218 |